Endovascular treatment of thoracic aortic diseases: Combined experience from the EUROSTAR and United Kingdom Thoracic Endograft registries

Leurs, Lina J.; Bell, Rachel E.; Degrieck, Yvan; Thomas, S; Hobo, Roel; Lundbom, Jan

doi:10.1016/j.jvs.2004.07.008

Cited by 498 publications

(384 citation statements)

References 50 publications

(71 reference statements)

Supporting

Mentioning

357

Contrasting

Unclassified

Order By: Relevance

“…Resultados semejantes de mortalidad y paraplejia postoperatoria se describen en pacientes provenientes de EUROSTAR y UK Registry tratados con endoprótesis por disección aórtica 30 .…”

Section: Discussionunclassified

Manejo endovascular de las complicaciones agudas de la disección aórtica tipo B

et al. 2010

Rev. méd. Chile

View full text Add to dashboard Cite

show abstract

“…Resultados semejantes de mortalidad y paraplejia postoperatoria se describen en pacientes provenientes de EUROSTAR y UK Registry tratados con endoprótesis por disección aórtica 30 .…”

Section: Discussionunclassified

Manejo endovascular de las complicaciones agudas de la disección aórtica tipo B

et al. 2010

Rev. méd. Chile

View full text Add to dashboard Cite

show abstract

“…Although perioperative and short-term results of TEVAR were encouraging, complications unique to this treatment, such as acute or delayed retrograde type A dissection (6 and 8%, respectively) [6], stroke (3%), paraplegia (2%), and endoleaks (4%) can contribute to mortality and complications after surgery [7].…”

Section: Case Reportmentioning

confidence: 99%

Complication of Endoleak and Retrograde Type A Dissection after Stenting of a Ruptured Type B Dissection

Kong¹,

Dong²,

Shen³

2015

Surgery Curr Res

View full text Add to dashboard Cite

“…The EUROSTAR study has demonstrated a rate of primary technical success of 89% in patients with aortic dissection (8) .…”

Section: (7)mentioning

confidence: 99%

“…Surgically treated dissections have a paraplegia incidence of 19%, but with the endovascular technique the incidence is around 0-10% (mean = 1.8%) (17)(18)(19) . The EUROSTAR registry presents paraplegia incidence of 4% in patients treated for aneurysms, and 0.8% for aortic dissections treated with endovascular approach (8) .…”

Section: (7)mentioning

confidence: 99%

See 1 more Smart Citation

Tratamento endovascular das doenças da aorta torácica: análise dos resultados de um centro

Novero¹,

Metzger²,

Obregon³

et al. 2012

Radiol Bras

View full text Add to dashboard Cite

Objective: To analyze treatment outcomes in a consecutive series of patients submitted to endovascular treatment of thoracic aortic disease. Technical success, therapeutic success, morbimortality, rate of perioperative complications and reinterventions were taken into consideration. Materials and Methods: The present retrospective study was developed in a reference center in the period from January 2010 to July 2011, involving patients submitted to endovascular treatment of thoracic aortic disease. The study population was divided into two groups: group 1 (G1) -true thoracic aortic aneurysms, aortic ulcer and pseudoaneurysm; group 2 (G2) -chronic type B aortic dissection. Results: Out of a total of 55 patients, 29 belonged to the G1 and 26 to the G2 group. Mean ages were 66.8 ± 10 and 56.4 ± 7 years, respectively. The technical and therapeutic success reached respectively 86.3% and 68.6% in G1 and 100% and 74% in G2. The perioperative mortality rate was 10.3% in G1 and 19.3% in G2. The reintervention rate was 10.3% in G1 and 15.3% in G2. Conclusion: In the present study, the endovascular treatment of thoracic aortic disease proved to be a feasible method associated with acceptable rate of complications. Keywords: Aneurysm; Vascular graft; Atherosclerosis.Objetivo: Analisar os resultados do tratamento de uma série consecutiva de pacientes submetidos a tratamento endovascular de doenças da aorta torácica. Foram observados o sucesso técnico, o sucesso terapêutico, a morbimortalidade e a taxa de complicações perioperatórias e de reintervenções. Materiais e Métodos: Estudo retrospectivo, realizado em um centro de referência, no período de janeiro de 2010 a julho de 2011, em que foram analisados pacientes submetidos a correção endovascular de doenças da aorta torácica. A população foi dividida em dois grupos: grupo 1 (G1) -aneurismas de aorta torácica verdadeiros, úlcera aórtica e pseudoaneurisma; grupo 2 (G2) -dissecção aórtica tipo B crônica. Resultados: Em um total de 55 pacientes tratados, 29 pertenciam ao G1 e 26, ao G2. As idades médias foram 66,8 ± 10 e 56,4 ± 7 anos, respectivamente. Os sucessos técnico e terapêutico foram, respectivamente, 86,3% e 68,6% no G1 e 100% e 74% no G2. A mortalidade perioperatória foi 10,3% no G1 e 7,6% no G2, com taxa de mortalidade anual de 10,3% no G1 e de 19,3% no G2. As taxas de reintervenções foram 10,3% e 15,3%, respectivamente. Conclusão: Em nosso estudo, o tratamento endovascular das doenças da aorta torácica demonstrou ser um método viável e associado a aceitáveis taxas de complicações. Unitermos: Aneurisma; Prótese vascular; Aterosclerose. . Aortic dissection is the most feared condition of the aorta and is twice as frequent as aortic rupture. The mortality rate associated with dissection ranges between 1% and 2% per hour, during the first 48 hours. Risk factors frequently associated with such condition include hypertension, cardiovascular and respiratory diseases. Dissection is three times more frequent in men than in women. The most common entry 7. PhD, Head

show abstract

Endovascular treatment of thoracic aortic diseases: Combined experience from the EUROSTAR and United Kingdom Thoracic Endograft registries

Cited by 498 publications

References 50 publications

Manejo endovascular de las complicaciones agudas de la disección aórtica tipo B

Manejo endovascular de las complicaciones agudas de la disección aórtica tipo B

Complication of Endoleak and Retrograde Type A Dissection after Stenting of a Ruptured Type B Dissection

Tratamento endovascular das doenças da aorta torácica: análise dos resultados de um centro

Contact Info

Product

Resources

About